|
|
Drug
Eluting Stent Summit-I |
• |
Updates
from¡¦SIRIUS: Lessons from
the Subgroup Analyses |
|
-Presenter : Gary S. Mintz, MD
-Reviewer : Jeffrey W. Moses, MD |
|
• |
The
TAXUS-IV "Mega-trial": Insights
from Subgroup Analyses |
|
-Presenter : Stephen G. Ellis, MD |
|
• |
New
Drug-Eluting Stents: Everolimus(FUTURE-I and
-II) and More |
|
- Presenter : Alan C. Yeung, MD
- Reviewer : Eberhard Grube, MD |
|
• |
Long
Cypher Multicenter Registry Study |
|
- Presenter : Seung-Jung Park, MD |
|
• |
New
Drug-Eluting Stent Trials: EASTER, IMPACT,
PISCES, BioRest, and More |
|
- Presenter : Alexandre Abizaid, MD |
|
• |
Drug-Eluting
Stenting: Update on ABT 578(PREFER, and ENDEAVOR-I)
|
|
- Presenter : Ian Meredith, MD |
|
Drug
Eluting Stent Summit-II |
|
Angiomyogenesis
Symposium: "From Bench To Bedside" |
|
Platelet
Inhibitors: From Bench To Bedside |
|
![](/image/summit/2004/title_icon.gif) |
Moving
Beyond Unfractionated Heparin
: LMWH, Direct Thrombin Inhibitors |
|
|
![](/image/summit/2004/title_icon.gif) |
Defending
the Microcirculation: Distal Protection and
Thrombectomy Devices |
|
|
![](/image/summit/2004/title_icon.gif) |
Management
of the Post-PCI Patient: Lipids and Beyond |
|
|
Clearing
the Way: Current Strategies for Peripheral Intervention |
|
Plenary
Sessions |
|
![](/image/summit/2004/title_icon.gif) |
Complex
Angioplasty: What Is Changing Now in the Era
of Drug Eluting Stent ?- Lt. Main, Bifurcation,
CTO |
|
|
![](/image/summit/2004/title_icon.gif) |
Cutting-edge
Strategies in Acute Coronary Syndromes and
Acute Myocardial Infarction |
|
|
![](/image/summit/2004/title_icon.gif) |
Why Not
Trans-Radial Intervention? |
|
Live
case transmissions from Ajou University Medical
Center, Korea |
|
|
![](/image/summit/2004/title_icon.gif) |
New Strategies
for Optimal Management of Acute Coronary Syndrome
with Agrastat to Zocor |
|
|
Drug Eluting Stent Summit-III |
|
Complementary Stenting - New Strategies in DES Era |
|
Vulnerable
Plaque: How To Detect? How To Treat? |
|
Plenary
Sessions |
|
|